ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types
Publication
, Conference
Rich, JN; Loncar, D; Sathornsumetee, S; Keir, S; Wheeler, C; Dimery, I; Bigner, DD; Friedman, HS
Published in: NEURO-ONCOLOGY
October 1, 2004
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
413 / 413
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rich, J. N., Loncar, D., Sathornsumetee, S., Keir, S., Wheeler, C., Dimery, I., … Friedman, H. S. (2004). ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types. In NEURO-ONCOLOGY (Vol. 6, pp. 413–413). Boston, MA: DUKE UNIV PRESS.
Rich, J. N., D. Loncar, S. Sathornsumetee, S. Keir, C. Wheeler, I. Dimery, D. D. Bigner, and H. S. Friedman. “ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types.” In NEURO-ONCOLOGY, 6:413–413. DUKE UNIV PRESS, 2004.
Rich JN, Loncar D, Sathornsumetee S, Keir S, Wheeler C, Dimery I, et al. ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types. In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 413–413.
Rich, J. N., et al. “ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types.” NEURO-ONCOLOGY, vol. 6, no. 4, DUKE UNIV PRESS, 2004, pp. 413–413.
Rich JN, Loncar D, Sathornsumetee S, Keir S, Wheeler C, Dimery I, Bigner DD, Friedman HS. ZD6474, a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor, inhibits growth of multiple primary central nervous system tumor types. NEURO-ONCOLOGY. DUKE UNIV PRESS; 2004. p. 413–413.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2004
Volume
6
Issue
4
Start / End Page
413 / 413
Location
Boston, MA
Publisher
DUKE UNIV PRESS
Conference Name
11th International Symposium on Pediatric Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences